BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11012753)

  • 1. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin.
    Matasic R; Dietz AB; Vuk-Pavlovic S
    Immunology; 2000 Sep; 101(1):53-60. PubMed ID: 11012753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
    Hackstein H; Morelli AE; Larregina AT; Ganster RW; Papworth GD; Logar AJ; Watkins SC; Falo LD; Thomson AW
    J Immunol; 2001 Jun; 166(12):7053-62. PubMed ID: 11390449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells.
    Matasić R; Dietz AB; Vuk-Pavlović S
    J Leukoc Biol; 1999 Dec; 66(6):909-14. PubMed ID: 10614771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
    Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
    Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of human dendritic cells as sulfasalazine target.
    Matasić R; Dietz AB; Vuk-Pavlović S
    Croat Med J; 2001 Aug; 42(4):440-5. PubMed ID: 11471196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4.
    Svajger U; Vidmar A; Jeras M
    Int Immunopharmacol; 2008 Jul; 8(7):997-1005. PubMed ID: 18486911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-prostaglandin effects of aspirin III and salicylate: inhibition of integrin-dependent human neutrophil aggregation and inflammation in COX 2- and NF kappa B (P105)-knockout mice.
    Weissmann G; Montesinos MC; Pillinger M; Cronstein BN
    Adv Exp Med Biol; 2002; 507():571-7. PubMed ID: 12664642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocytes but not dendritic cells are killed by blocking of autocrine cyclooxygenase activity.
    Oliveira BL; Cavalcanti CM; Azevedo AP; Tomiyoshi MY; Bergami-Santos PC; Barbuto JA
    Cell Immunol; 2009; 258(1):107-14. PubMed ID: 19394592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PAF-receptor induces regulatory dendritic cells through PGE2 and IL-10.
    Koga MM; Bizzarro B; Sá-Nunes A; Rios FJ; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):319-26. PubMed ID: 24120121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
    Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
    Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin.
    Cianferoni A; Schroeder JT; Kim J; Schmidt JW; Lichtenstein LM; Georas SN; Casolaro V
    Blood; 2001 Mar; 97(6):1742-9. PubMed ID: 11238116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
    Hinz B; Kraus V; Pahl A; Brune K
    Biochem Biophys Res Commun; 2000 Jul; 274(1):197-202. PubMed ID: 10903918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other anti-inflammatory drugs.
    Vane SJ
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S3-9. PubMed ID: 10992545
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-inflammatory effects of aspirin and sodium salicylate.
    Amann R; Peskar BA
    Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of aspirin and salicylic acid with prednisolone for inhibition of lymphocyte proliferation.
    Ramakrishnan R; Jusko WJ
    Int Immunopharmacol; 2001 Oct; 1(11):2035-42. PubMed ID: 11606034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and the prevention of colorectal cancer.
    Berman KS
    N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
    Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
    Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.